WRBY
Warby Parker Inc.
NYSE · USHealthcareMedical - Instruments & Supplies
$24.59-6.89%
Price as of Jul 20, 2026
WRBY financials
Warby Parker Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $871.9M | $771.3M | $669.8M | $598.1M |
| Cost of revenue | $401.3M | $344.5M | $304.5M | $257.1M |
| Gross profit | $470.6M | $426.8M | $365.2M | $341.1M |
| Operating expenses | $475.9M | $456.9M | $437.2M | $452.3M |
| Operating income | -$5.3M | -$30.1M | -$72.0M | -$111.2M |
| Net income | $1.6M | -$20.4M | -$63.2M | -$110.4M |
| EBITDA | $53.3M | $26.4M | -$24.2M | -$78.0M |
| Basic EPS | $0.01 | $-0.17 | $-0.54 | $-0.96 |
| Diluted EPS | $0.01 | $-0.17 | $-0.54 | $-0.96 |
| Balance sheet | ||||
| Cash & equivalents | $286.4M | $254.2M | $216.9M | $208.6M |
| Total assets | $720.9M | $676.5M | $580.3M | $568.7M |
| Total liabilities | $353.2M | $336.4M | $278.5M | $282.1M |
| Stockholders’ equity | $367.7M | $340.1M | $301.8M | $286.6M |
| Total debt | $233.1M | $225.4M | $174.5M | $173.4M |
| Net debt | -$53.2M | -$28.8M | -$42.4M | -$35.2M |
| Cash flow | ||||
| Operating cash flow | $110.8M | $98.7M | $61.0M | $10.4M |
| Capital expenditure | -$67.0M | -$64.0M | -$53.7M | -$60.2M |
| Free cash flow | $43.7M | $34.7M | $7.3M | -$49.8M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |